Americas Ultrasound Ablation Market
- Report Code: UL 1001
- Publish Date: Upcoming
The American Ultrasound Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $644 million in 2013 and is expected to reach $1155 million by 2018.
The report “Ultrasound Ablation Market forecast, 2010-2018” analyzes the market of devices by segments such as High Intensity Focused Ultrasound, Magnetic Resonance Imaging-Guided Focused Ultrasound, Ultrasound Surgical Systems, and Shock wave therapy. All of these segments experienced a positive growth with an increased awareness of patients and physicians towards the usage and reception of new ablation technologies due to the numerous advantages offered by these devices. This technique finds maximum applications in the gynecology segment such as removal of uterine fibroids, cancer of the prostate, and testes. It also finds large application in treatment of atrial fibrillation, arrhythmia and other cancers such as those of liver and breasts.
The ultrasound ablation market is growing significantly due to its non-invasive nature, not requiring even a laparoscopic procedure. Older population is growing in the mature markets such as U.S. Currently, in the U.S., 40 million people are aged 65 and above and it is expected that by 2050 this number will increase to 89 million. The diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems are on the rise. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for ultrasound ablation devices.
High treatment seeking population and continuously increasing incidence of diseases such as cancer and problems related to heart, orthopedics, gynecology and urology, offers good opportunity for ultrasound ablation devices market in America. SEER estimated that in U.S. 1,596,670 cancer patients will be diagnosed in 2011, in addition coronary artery disease is considered as one of the important causes of death in the U.S. Due to huge obese population (~30% of U.S. population) and high diabetic patient pool, it is expected that incidences of cardiovascular related disorders will continue to grow in the future.
The report also provides an extensive competitive landscaping of companies operating in ultrasound ablation market. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
The market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Americas Thermal Ablation The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others |
Upcoming |
|
|
Asia-Pacific Thermal Ablation The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
European Thermal Ablation The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
